119 related articles for article (PubMed ID: 21463902)
1. Recommendations to improve the positive and negative syndrome scale (PANSS) based on item response theory.
Levine SZ; Rabinowitz J; Rizopoulos D
Psychiatry Res; 2011 Aug; 188(3):446-52. PubMed ID: 21463902
[TBL] [Abstract][Full Text] [Related]
2. Revisiting the 5 dimensions of the Positive and Negative Syndrome Scale.
Levine SZ; Rabinowitz J
J Clin Psychopharmacol; 2007 Oct; 27(5):431-6. PubMed ID: 17873671
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
Bobes J; Arango C; Garcia-Garcia M; Rejas J;
J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
[TBL] [Abstract][Full Text] [Related]
4. The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials.
Kinon BJ; Ascher-Svanum H; Adams DH; Chen L
J Clin Psychopharmacol; 2008 Oct; 28(5):544-9. PubMed ID: 18794651
[TBL] [Abstract][Full Text] [Related]
5. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
[TBL] [Abstract][Full Text] [Related]
6. Standardized assessment of psychopathology by relatives of mentally disordered patients. Preliminary results of using the positive and negative syndrome scale to compare schizophrenic and affective disorders.
Nitsche I; Kallert TW
Psychopathology; 2007; 40(4):242-53. PubMed ID: 17440287
[TBL] [Abstract][Full Text] [Related]
7. The relationship between insight and symptoms in schizophrenia.
Sevy S; Nathanson K; Visweswaraiah H; Amador X
Compr Psychiatry; 2004; 45(1):16-9. PubMed ID: 14671732
[TBL] [Abstract][Full Text] [Related]
8. [Core factors of schizophrenia structure based on PANSS and SAPS/SANS results. Discerning and head-to-head comparisson of PANSS and SASPS/SANS validity].
Masiak M; Loza B
Psychiatr Pol; 2004; 38(5):795-808. PubMed ID: 15523927
[TBL] [Abstract][Full Text] [Related]
9. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
Olié JP; Spina E; Murray S; Yang R
Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
[TBL] [Abstract][Full Text] [Related]
10. Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia.
Velligan DI; Alphs L; Lancaster S; Morlock R; Mintz J
Psychiatry Res; 2009 Sep; 169(2):97-100. PubMed ID: 19664826
[TBL] [Abstract][Full Text] [Related]
11. Patient-based and clinician-based support for the remission criteria in schizophrenia.
Docherty JP; Bossie CA; Lachaux B; Bouhours P; Zhu Y; Lasser R; Gharabawi GM
Int Clin Psychopharmacol; 2007 Jan; 22(1):51-5. PubMed ID: 17159460
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p.r.n. medication.
Chaichan W
J Psychiatr Pract; 2008 Mar; 14(2):105-13. PubMed ID: 18360196
[TBL] [Abstract][Full Text] [Related]
13. The Positive and Negative Syndrome Scale--Spanish adaptation.
Kay SR; Fiszbein A; Vital-Herne M; Fuentes LS
J Nerv Ment Dis; 1990 Aug; 178(8):510-7. PubMed ID: 2380697
[TBL] [Abstract][Full Text] [Related]
14. Psychotic symptoms in patients with bipolar mania.
Canuso CM; Bossie CA; Zhu Y; Youssef E; Dunner DL
J Affect Disord; 2008 Dec; 111(2-3):164-9. PubMed ID: 18378001
[TBL] [Abstract][Full Text] [Related]
15. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
Loas G; Noisette C; Legrand A; Delahousse J
Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
[TBL] [Abstract][Full Text] [Related]
16. Relationship of "prodromal" symptoms with severity and type of psychopathology in the active phase of schizophrenia.
Moukas G; Stathopoulou A; Gourzis P; Beratis IN; Beratis S
Compr Psychiatry; 2010; 51(1):1-7. PubMed ID: 19932819
[TBL] [Abstract][Full Text] [Related]
17. Testosterone in first-episode schizophrenia.
Cesková E; Prikryl R; Kaspárek T
Neuro Endocrinol Lett; 2007 Dec; 28(6):811-4. PubMed ID: 18063925
[TBL] [Abstract][Full Text] [Related]
18. To what extent do the PANSS and CGI-S overlap?
Rabinowitz J; Mehnert A; Eerdekens M
J Clin Psychopharmacol; 2006 Jun; 26(3):303-7. PubMed ID: 16702895
[TBL] [Abstract][Full Text] [Related]
19. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
20. Clinical use of the Hamilton Depression Rating Scale: is increased efficiency possible? A post hoc comparison of Hamilton Depression Rating Scale, Maier and Bech subscales, Clinical Global Impression, and Symptom Checklist-90 scores.
Ruhé HG; Dekker JJ; Peen J; Holman R; de Jonghe F
Compr Psychiatry; 2005; 46(6):417-27. PubMed ID: 16275208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]